Cure TV

Debu Tripathy, editor-in-chief of CURE magazine, reports from the San Antonio Breast Breast Cancer Symposium where a study involving the PI3 kinase inhibitor pictilisib showed interesting results.

Debu Tripathy, editor-in-chief of CURE magazine, recaps the first day of the San Antonio Breast Cancer Symposium - namely the advances in treating breast cancer with immunotherapy.

Lee Greenberger, of the Leukemia & Lymphoma Society, explains how immunotherapy research has progressed in hematological cancers and the potential for these burgeoning therapies.

Anne Young Quinn, of the MMRF, explains the catalyst behind the CoMMpass study and how it may be changing the future of myeloma treatment.

Richard Silver, an oncologist focused on rare blood diseases called myeloproliferative neoplasms was named an MPN Hero for Commitment to the Broader MPN Community for 2014.

David Alexander was selected as an MPN Hero at this year's MPN Heroes event. The MPN Heroes event honors clinicians, caregivers, and advocates who have made significant contributions in the field of myeloproliferative neoplasms (MPNs).

Antje Hjerpe was nominated as an MPN Hero for her long-term dedication, stewardship and volunteer service to the organization.

New York artist and GIST survivor, Ellen Mayer, painted "Balancing Act" to describe how she felt about her cancer experience. The artwork was later selected as one of 10 pieces to be publicly painted for The Hope Murals Project.

Susan Hope Schaffer, the 2014 Oncology on Canvas overall winner, shares how her experience with breast cancer helped her evolve as an artist.

Patrick Borgen, MD, talks about advances in breast cancer surgery, faster clinical trials, and better genomic profiling.

Breast cancer is a complicated family of diseases – the goal is personalized medicine, and a team-based approach should be the standard of care.

Several studies announcing the latest research in different cancers, including prostate, breast and lung cancers, were presented at the 2014 European Society of Medical Oncology's annual meeting in Madrid, Spain.

Patrick Borgen, MD, discusses the benefits of early detection versus overtreatment of breast cancer associated with routine breast cancer screening.

Patrick Borgen, MD, shares his thoughts on the ethics and the efficacy of undergoing pre-emptive double mastectomy in women who have a BRCA mutation, which can greatly increase their risk for breast and ovarian cancers.

Experts review an innovative study, called the ATEMPT study, which looks at adjuvant T-DM1 in women with HER2-positive breast cancer.

Debu Tripathy, MD, editor-in-chief of CURE magazine, shares the latest research in metastatic breast cancer, including targeted drugs being tested in early-phase studies that appear promising, including the PARP inhibitor veliparib, the CDK4/6 inhibitor palbociclib and the anti-angiogenesis drug trametinib.